爱威科技股价近期波动上涨，政策利好IVD行业转型

Group 1 - The stock price of Awei Technology (688067) has shown a fluctuating upward trend in the past week, with a cumulative increase of 2.69% and a volatility of 6.16% [1] - On February 9, the stock price rose by 2.07% to close at 29.05 yuan, with a net inflow of 3.29 million yuan from main funds; on February 10, the stock price adjusted by 0.96%, but main funds still saw a net inflow of 3.80 million yuan [1] - As of February 11, the latest stock price was 29.00 yuan, with a daily increase of 0.80%, indicating a high level of market attention reflected in the overall net inflow of main funds [1] Group 2 - On February 5, the National Medical Insurance Administration issued a notice to accelerate the cultivation of scenarios in the medical insurance field, focusing on innovation in medical insurance services, which may bring new market opportunities for IVD companies like Awei Technology [2] - The company has recently indicated through investor interactions that it has expanded downstream testing services by establishing new subsidiaries (such as Hunan Awei Testing and Beijing Awei Intelligent Testing), implementing a "device + service" dual-driven strategy [2] Group 3 - Xiangcai Securities released a report on February 8 stating that despite a 1.28% decline in the IVD sector that week, Awei Technology performed well with a weekly increase of 1.4% [3] - The report suggests that the IVD industry is expected to accelerate its integration with AI and medical insurance payments driven by policy changes, which will benefit companies with the capability to integrate technology and services in the long term [3]